Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹6,204 Cr
up ₹665 Cr vs Oct 2023
- Stocks held
- 31
- up 1 vs Oct 2023
- Top 10 weight
- 59.0%
- of the portfolio in its ten largest
- Cash & debt
- 0.5%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 10, trimmed 1
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In November 2023 it disclosed 31 stocks worth ₹6,204 Cr, up ₹665 Cr from Oct 2023. Its largest positions were Sun Pharmaceutical Industries Limited (13.0%), Lupin Limited (7.9%), Cipla Limited (6.1%); the ten largest together made up 59.0% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 76.6% of its equity. Cash and debt stood at 0.5%. Compared with Oct 2023 the fund entered 1 new stock and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
81%
Top-10 weight is higher than 81% of peers
Breadth
16%
Holds more stocks than 16% of peers
Cash
7%
Holds more cash than 7% of peers
Holdings in November 2023
Download CSVEvery line the fund disclosed, with the change against Oct 2023. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 12.95%
- Δ weight
- up 0.07 pts
- Value
- ₹804 Cr
- Δ value
- up ₹90 Cr
- Status
- Added
- Weight
- 7.85%
- Δ weight
- up 0.11 pts
- Value
- ₹487 Cr
- Δ value
- up ₹58.1 Cr
- Status
- Added
- Weight
- 6.06%
- Δ weight
- down 0.44 pts
- Value
- ₹376 Cr
- Δ value
- up ₹15.8 Cr
- Status
- Added
- Weight
- 5.78%
- Δ weight
- up 1.31 pts
- Value
- ₹359 Cr
- Δ value
- up ₹111 Cr
- Status
- Added
- Weight
- 5.13%
- Δ weight
- down 0.20 pts
- Value
- ₹318 Cr
- Δ value
- up ₹23.1 Cr
- Status
- Added
- Weight
- 4.86%
- Δ weight
- up 0.68 pts
- Value
- ₹302 Cr
- Δ value
- up ₹69.8 Cr
- Status
- Added
- Weight
- 4.58%
- Δ weight
- up 0.30 pts
- Value
- ₹284 Cr
- Δ value
- up ₹47 Cr
- Status
- Added
- Weight
- 4.20%
- Δ weight
- up 0.36 pts
- Value
- ₹260 Cr
- Δ value
- up ₹48 Cr
- Status
- Added
- Weight
- 3.95%
- Δ weight
- down 0.44 pts
- Value
- ₹245 Cr
- Δ value
- up ₹1.8 Cr
- Status
- Added
- Weight
- 3.65%
- Δ weight
- up 0.24 pts
- Value
- ₹227 Cr
- Δ value
- up ₹37.5 Cr
- Status
- Added
- Weight
- 3.48%
- Δ weight
- down 0.30 pts
- Value
- ₹216 Cr
- Δ value
- up ₹6.4 Cr
- Status
- Added
- Weight
- 3.29%
- Δ weight
- down 0.03 pts
- Value
- ₹204 Cr
- Δ value
- up ₹20.5 Cr
- Status
- Added
- Weight
- 3.25%
- Δ weight
- down 0.23 pts
- Value
- ₹202 Cr
- Δ value
- up ₹8.7 Cr
- Status
- Added
- Weight
- 3.08%
- Δ weight
- up <0.01 pts
- Value
- ₹191 Cr
- Δ value
- up ₹20.6 Cr
- Status
- Added
- Weight
- 3.06%
- Δ weight
- up 0.36 pts
- Value
- ₹190 Cr
- Δ value
- up ₹40.3 Cr
- Status
- Added
- Weight
- 3.06%
- Δ weight
- down 0.16 pts
- Value
- ₹190 Cr
- Δ value
- up ₹11.4 Cr
- Status
- Added
- Weight
- 3.00%
- Δ weight
- down 0.08 pts
- Value
- ₹186 Cr
- Δ value
- up ₹15.3 Cr
- Status
- Added
- Weight
- 2.93%
- Δ weight
- down 0.16 pts
- Value
- ₹182 Cr
- Δ value
- up ₹10.6 Cr
- Status
- Added
- Weight
- 2.28%
- Δ weight
- up 1.62 pts
- Value
- ₹142 Cr
- Δ value
- up ₹105 Cr
- Status
- Added
- Weight
- 2.18%
- Δ weight
- up 0.14 pts
- Value
- ₹135 Cr
- Δ value
- up ₹22.1 Cr
- Status
- Added
- Weight
- 2.07%
- Δ weight
- down 0.03 pts
- Value
- ₹128 Cr
- Δ value
- up ₹12.2 Cr
- Status
- Added
- Weight
- 1.93%
- Δ weight
- down 0.15 pts
- Value
- ₹120 Cr
- Δ value
- up ₹4.4 Cr
- Status
- Added
- Weight
- 1.59%
- Δ weight
- down 0.16 pts
- Value
- ₹98.9 Cr
- Δ value
- up ₹1.9 Cr
- Status
- Added
- Weight
- 1.08%
- Δ weight
- up 0.04 pts
- Value
- ₹67 Cr
- Δ value
- up ₹9.4 Cr
- Status
- Added
- Weight
- 1.07%
- Δ weight
- up 0.02 pts
- Value
- ₹66.5 Cr
- Δ value
- up ₹8.2 Cr
- Status
- Added
- Weight
- 0.92%
- Δ weight
- up 0.07 pts
- Value
- ₹56.9 Cr
- Δ value
- up ₹9.9 Cr
- Status
- Added
- Weight
- 0.85%
- Δ weight
- down 0.01 pts
- Value
- ₹52.8 Cr
- Δ value
- up ₹5 Cr
- Status
- Added
- Weight
- 0.57%
- Δ weight
- up 0.57 pts
- Value
- ₹35.6 Cr
- Δ value
- up ₹35.6 Cr
- Status
- New
- Cash, TREPS & receivables
- Weight
- 0.49%
- Δ weight
- down 3.43 pts
- Value
- ₹30.3 Cr
- Δ value
- down ₹187 Cr
- Status
- Trimmed
- Weight
- 0.38%
- Δ weight
- up 0.01 pts
- Value
- ₹23.6 Cr
- Δ value
- up ₹3 Cr
- Status
- Added
- Weight
- 0.24%
- Δ weight
- down 0.03 pts
- Value
- ₹14.8 Cr
- Δ value
- down ₹3 L
- Status
- Held
- Weight
- 0.16%
- Δ weight
- down 0.03 pts
- Value
- ₹10.1 Cr
- Δ value
- down ₹35 L
- Status
- Trimmed
What changed, Oct 2023 to Nov 2023
New New positions (1)
- Metropolis Healthcare Limited0.6% · ₹35.6 Cr
Exited Exited (0)
None.
Added Biggest additions
- Apollo Hospitals Enterprise Limitedup ₹111 Cr (+1.31% pts)
- GlaxoSmithKline Pharmaceuticals Limitedup ₹105 Cr (+1.62% pts)
- Sun Pharmaceutical Industries Limitedup ₹90 Cr (+0.07% pts)
- Gland Pharma Limitedup ₹69.8 Cr (+0.68% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Oct 2023, the weight rose most in Healthcare Services (+1.2 pts), and fell most in Retailing (−0.6 pts) and Pharmaceuticals & Biotechnology (−0.6 pts).
- Healthcare Services17.0% → 18.2%+1.2 pts
- Retailing4.6% → 4.0%−0.6 pts
- Pharmaceuticals & Biotechnology77.2% → 76.6%−0.6 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Nov 2020 | Nov 2022 | May 2023 | Aug 2023 | Oct 2023 | Nov 2023 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 79.0% | 78.5% | 76.3% | 77.8% | 77.2% | 76.6% |
| Healthcare Services | 18.8% | 19.5% | 18.5% | 16.3% | 17.0% | 18.2% |
| Retailing | — | 0.1% | 3.5% | 4.7% | 4.6% | 4.0% |
| Pharmaceuticals | 2.2% | 1.5% | 1.4% | 1.1% | 1.1% | 1.1% |
| Healthcare Equipment & Supplies | — | 0.3% | 0.3% | 0.2% | 0.2% | 0.2% |
Allocation in Nov 2023change vs Oct 2023
- Pharmaceuticals & Biotechnology (20)76.6%▼ 0.6 pts
- Healthcare Services (8)18.2%▲ 1.2 pts
- Retailing (1)4.0%▼ 0.6 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Nov 2023
0.5%
▼ 3.4 pts vs Oct 2023
- Cash alone
- 0.5%
- cash and net receivables
- A year earlier
- 0.4%
- Nov 2022 · now ▲ 0.1 pts
- Last 12 months
- 0.4% – 3.9%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.